CAMPBELL, Calif. April 30, 2024 – Saama, a leader of AI-based clinical trial solutions and services that accelerate drug development and commercialization, is pleased to announce the appointment of Ari Srinivasan as Chief Customer Success and Growth Officer. Ari brings to Saama his deep experience within the life sciences industry leading teams focused on harnessing the power of technology and data-driven insights to improve healthcare. In this role, Ari is responsible for driving growth for both Saama’s AI-driven SaaS platform, as well as product based industry solutions and accelerators for customers. Additionally, he will be focused on working with Saama’s partners to ensure satisfaction and success. As part of the executive management team, he will also work to identify the collective synergies from within the company and across partners that will help shape future industry innovation with the aim to improve the lives of patients.
With a career that spans nearly three decades, Ari has been instrumental in transforming the technology and business ecosystems across large global Fortune 100 clients to early-stage start-up biotechs. His success in establishing and managing product ventures, specifically leveraging data-driven insights, AI/ML, and real-world evidence, has supported life sciences companies to optimize their drug development, clinical studies, and commercial operations. Most recently, Ari was Group EVP at Real Chemistry, leading their Data & AI solutions teams in the implementation of technologies to enable more efficient commercial & clinical ecosystems. Prior to that, he led strategic business units, practices & partnerships at Cognizant, IBM, and Cegedim, where he was able to tap into his hybrid expertise on both the product and services sides of the business.
“We are thrilled to have Ari join Saama’s leadership team,” said Bhaskar Sambasivan, Chief Executive Officer, Saama. “With the power of our evolving AI-enabled technology platform, and a dedicated AI research and innovation group, we are uniquely positioned to lead the current transformation in clinical research, and Ari’s experience and expertise in industry & AI solutions, especially with a customer first approach, will help to drive advances forward for our customers and the business.”
“It is an honor to join Saama at such a pivotal time,” echoed Ari. “The convergence of healthcare and technology have led to advances in clinical research that were previously unachievable. Saama is driven by the power of an AI-driven platform & the passion of our people with extensive domain experiences. I am confident in us collaboratively working with our client teams to drive efficiencies and achieve better collaboration in clinical trials, all with an intent to bring therapies to market faster & improve the quality of patients’ lives.”
About Saama
Saama develops life science solutions that accelerate the delivery of therapies to patients. With innovative AI technologies, Saama drives breakthrough intelligence into clinical and commercial operations. The Saama platform powered the clinical trial that led to the world’s first COVID-19 vaccine. Headquartered in Campbell, CA, with employees around the globe, Saama is committed to helping customers save and improve lives. Discover more at saama.com.
Contacts:
Kate Mikus
Senior Director, Marketing
[email protected]
Heather Shea
Catalytic Agency on behalf of Saama
[email protected]
